Drugs policy inquiry
Inquiry by the Health and Social Care Committee, 6 December 2018 to 6 December 2018. Its page on the Parliament website.
Reports and responses
- 1st Report - Drugs policy (23 October 2019)
Evidence sessions
- 7 May 2019: Mark Johnson, Chief Executive Officer, User Voice, Professor Susanne MacGregor, Honorary Professor of Social Policy, London School of Hygiene and Tropical Medicine, Professor Tim Millar, Professor of Substance Use and Addictions, University of ManchesterKaren Biggs, Chair, Collective Voice, Boris Pomroy, Chief Executive, Mentor, Professor Harry Sumnall, Professor in Substance Use, Liverpool John Moores University, Mike Flanagan, Consultant Nurse and Clinical Lead, Drug and Alcohol Services, Surrey and Borders Partnership NHS Foundation TrustKirstie Douse, Head of Legal Services, Release, Adrian Crossley, Head of Addiction, Centre for Social Justice
- 11 June 2019: Josie Smith, Head of Substance Misuse Programme, Public Health Wales, Yusef Azad, Director of Strategy, National AIDS Trust, Matthew Hickman, Professor in Public Health and Epidemiology, University of BristolDanny Hames, Chair, NHS Substance Misuse Providers Alliance, Peter Yarwood, Chief Executive Officer, Red Rose Recovery & Lancashire User Forum, Professor Sir John Strang, Head of the Addictions Department, Kings College London, Dr Arun Dhandayudham, Joint CEO and Medical Director, Westminster Drugs Project
- 2 July 2019: Jason Harwin, Deputy Chief Constable, National Police Chief Council, Dr Wojciech Spyt, Detective Sergeant, Thames Valley Police, Hardyal Dhindsa, Association of Police and Crime Commissioners, Stephanie Kilili, Policy Advisor, Office of the Durham Police, Crime and Victims’ CommissionerMark Johnson, Chief Executive Officer, User Voice, Emily Giles, Policy and Communications Coordinator, ADFAM, Kerrie Hudson, Operational Lead, The Well